SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility and intense community debate as investors navigate a disconnect between its strong growth narrative and a persistent stock price slide near 52-week lows. While bulls point to robust product demand, the Alani Nu acquisition, and a potential post-earnings recovery, many are frustrated by the stock's failure to participate in broader market rallies, leading to heightened speculation about institutional manipulation and upcoming earnings catalysts.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following an official determination from NOAA that its deep-seabed mining application is in full compliance, a key milestone that clarifies the regulatory path toward commercial operations. Community members are actively debating the significance of this news for long-term permitting and discussing whether the stock is positioned for a sustained rally despite recent volatility.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending after announcing a strategic manufacturing partnership with Cellipont Bioservices to advance its ERNA-101 ovarian cancer therapy toward clinical trials. While some investors are excited by the potential for a short squeeze given the stock's low float and high volume, others remain skeptical, citing concerns over historical dilution and the speculative nature of early-stage biotech.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors digest a surprise revenue beat and significant cost reductions following the latest earnings call, while community discourse remains intensely focused on the potential of the Matrix-M adjuvant and activist pressure for management changes. Sentiment remains polarized between those betting on long-term partnership success and shareholders frustrated by stalled pipeline execution and the ongoing proxy battle.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community speculation as traders position for upcoming earnings, with many focusing on the potential for a short squeeze or a major move based on management's turnaround strategy. Discussions are heavily divided between bullish sentiment regarding the company's housing technology, institutional accumulation, and AI initiatives, versus skepticism about the firm's long-term housing market performance and profitability.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is trending as investors weigh its role as a fundamental backbone of the AI data-center buildout against volatility following recent earnings and management comments regarding supply chain constraints. Despite a sharp post-earnings dip, the community remains divided between those capitalizing on the sell-off as a long-term opportunity and those concerned that the stock's premium valuation leaves little room for margin pressure.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and community debate as investors weigh the company's recent siRNA pipeline updates and Elevidys revenue growth against ongoing regulatory scrutiny and analyst skepticism regarding clinical data. The stock is currently a major focus for traders discussing potential short-squeeze dynamics and the long-term outlook for its Duchenne muscular dystrophy gene therapy franchise.

Applied Digital Corporation

Applied Digital is trending as investors bet on its massive backlog of AI data center contracts and infrastructure capacity, leading to strong bullish momentum and active discussion regarding a potential short squeeze. The community is focused on the stock's ability to maintain its upward trajectory toward new highs as it continues to execute on its large-scale AI hyperscaler partnerships.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing significant volatility following a record-breaking earnings report that highlighted strong revenue growth, improved margins, and robust bookings. Community members are actively debating the sustainability of the stock's recent momentum, with some focusing on its long-term potential as a rugged edge-computing and defense infrastructure play, while others remain cautious of short-term pullbacks and selling pressure.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV remains a focal point for investors as the community debates the stock's future, weighing potential synergies from its Disney partnership against frustration over persistent subscriber losses and a history of shareholder dilution. While some traders are positioning for a potential short squeeze or a turnaround fueled by live sports rights, others express deep skepticism regarding management's credibility and the company's path to consistent profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before...

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Novo Nordisk stock jumps as Q1 earnings and revenues beat estimates, fueled by strong Wegovy and Ozempic demand and a raised 2026 outlook.

Private Payrolls Increased More Than Expected

ADP +109K: Job Growth on Lower-Paying Work

Beyond obvious strength in Healthcare, we're starting to see "green shoots" in industries that a year ago were seeing negative growth.

Novo Raises Forecast as Wegovy Pill Fuels Sales

Novo Nordisk said this year's declines won't be as bad as initially expected thanks to the new Wegovy pill, which helped fuel sales in the first quarter. For the year, the worst drop for both profit...

Deja Vu All Over Again: Futures Surge, Oil Tumbles On Iran Deal Optimism, Tech Rally

Deja Vu All Over Again: Futures Surge, Oil Tumbles On Iran Deal Optimism, Tech Rally US equity futures are up big this morning and making fresh all time highs, led by tech companies, while oil prices...

Wegovy Pill Debut 'Fattens' Novo Nordisk's Profit Outlook

Novo Nordisk ($NVO) stock jumps as the company raises 2026 guidance. Strong Q1 sales beat estimates, driven by massive GLP-1 drug demand.read more...

Novo Nordisk beats estimates and shares surge on demand for weight loss pill

First-quarter sales of the oral Wegovy pill hit $353 million, more than double analyst expectations, as the company lifted its full-year outlook...

'Project Freedom' Pause, Stocks Rally as AI Spend Drives Tech  The Opening Trade 5/6/2026

Technology stocks are driving rallies in global equities as a wave of blockbuster earnings and deals highlights the relentless pace of investment in artificial intelligence. Investors' optimism was...

Truist Financial Corp Trims Stake in Novo Nordisk A/S $NVO

Truist Financial Corp trimmed its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 11.0% in the 4th quarter, according to the company in its most recent disclosure with the...

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Stocktwits

Stocktwits Polls

Novo Nordisk A/S

Explosive sales volume and mass-market adoption of the new oral GLP-1 treatment is the primary driver of investor sentiment.

The upward revision to fiscal year outlooks has shifted the narrative from stagnation to recovery and aggressive growth.

Traders are highlighting superior market share gains against key obesity treatment rivals, fueling bullish breakouts expectations.

Frustrated investors see the recent price action as the beginning of a significant squeeze against deep-seated bear sentiment.

NVO
Novo Nordisk A/S

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest NVO News

NVONovo Nordisk A/S